Anthony Lynch

865 total citations
13 papers, 324 citations indexed

About

Anthony Lynch is a scholar working on Cancer Research, Health, Toxicology and Mutagenesis and Molecular Biology. According to data from OpenAlex, Anthony Lynch has authored 13 papers receiving a total of 324 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Cancer Research, 5 papers in Health, Toxicology and Mutagenesis and 4 papers in Molecular Biology. Recurrent topics in Anthony Lynch's work include Carcinogens and Genotoxicity Assessment (5 papers), Effects and risks of endocrine disrupting chemicals (2 papers) and Drug Transport and Resistance Mechanisms (2 papers). Anthony Lynch is often cited by papers focused on Carcinogens and Genotoxicity Assessment (5 papers), Effects and risks of endocrine disrupting chemicals (2 papers) and Drug Transport and Resistance Mechanisms (2 papers). Anthony Lynch collaborates with scholars based in United Kingdom, United States and Germany. Anthony Lynch's co-authors include John Nicolette, Véronique Thybaud, Azeddine Elhajouji, Svetlana L. Avlasevich, Freddy Van Goethem, Jian Shi, M. De Boeck, Stephen D. Dertinger, Steven M. Bryce and Krista L. Dobo and has published in prestigious journals such as Archives of Toxicology, Mutation Research/Genetic Toxicology and Environmental Mutagenesis and Regulatory Toxicology and Pharmacology.

In The Last Decade

Anthony Lynch

13 papers receiving 309 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anthony Lynch United Kingdom	8	160	135	95	53	43	13	324
Ji‐Eun Seo United States	13	175 1.1×	160 1.2×	82 0.9×	38 0.7×	26 0.6×	28	349
Esther Vock Germany	9	151 0.9×	131 1.0×	81 0.9×	38 0.7×	23 0.5×	16	337
Xilin Li United States	14	101 0.6×	138 1.0×	48 0.5×	48 0.9×	28 0.7×	26	359
Wang Rui-Sheng Japan	11	178 1.1×	124 0.9×	90 0.9×	22 0.4×	95 2.2×	14	441
Christine C. Hedli United States	8	237 1.5×	188 1.4×	154 1.6×	27 0.5×	24 0.6×	10	503
T. Green United Kingdom	11	195 1.2×	193 1.4×	90 0.9×	32 0.6×	20 0.5×	13	391
Louise Latriano United States	12	251 1.6×	170 1.3×	160 1.7×	38 0.7×	22 0.5×	22	538
Hans‐Joerg Martus Switzerland	10	188 1.2×	118 0.9×	94 1.0×	83 1.6×	22 0.5×	19	357
Michael A. Shultz United States	8	108 0.7×	88 0.7×	70 0.7×	18 0.3×	44 1.0×	12	308
Masako Muguruma Japan	12	91 0.6×	237 1.8×	42 0.4×	25 0.5×	99 2.3×	28	425

Countries citing papers authored by Anthony Lynch

Since Specialization

Citations

This map shows the geographic impact of Anthony Lynch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anthony Lynch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anthony Lynch more than expected).

Fields of papers citing papers by Anthony Lynch

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anthony Lynch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anthony Lynch. The network helps show where Anthony Lynch may publish in the future.

Co-authorship network of co-authors of Anthony Lynch

This figure shows the co-authorship network connecting the top 25 collaborators of Anthony Lynch. A scholar is included among the top collaborators of Anthony Lynch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anthony Lynch. Anthony Lynch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Parry, Joel D., Patrik Andersson, Anthony Lynch, et al.. (2025). Opportunities for More Tailored Approaches to Genotoxicity Testing and Carcinogenicity Strategy for Oligonucleotide Therapeutics: Outcome of an Industry Survey. Nucleic Acid Therapeutics. 35(1). 34–48. 1 indexed citations

Zeiger, Errol, et al.. (2025). A comparative analysis of select P450 enzymes in uninduced and PB/BNF-induced hamster and rat liver S9. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 902. 503855–503855. 2 indexed citations

Jardí, Ferran, Cecelia Kelly, Daniel C. Sévin, et al.. (2022). Mouse organoids as an in vitro tool to study the in vivo intestinal response to cytotoxicants. Archives of Toxicology. 97(1). 235–254. 7 indexed citations

Trejo‐Martin, Alejandra, Joel P. Bercu, Rachael E. Tennant, et al.. (2022). Use of the bacterial reverse mutation assay to predict carcinogenicity of N-nitrosamines. Regulatory Toxicology and Pharmacology. 135. 105247–105247. 31 indexed citations

Rodrigues, Daniela, Luke Coyle, Matteo Piazza, et al.. (2021). New insights into the mechanisms underlying 5-fluorouracil-induced intestinal toxicity based on transcriptomic and metabolomic responses in human intestinal organoids. Archives of Toxicology. 95(8). 2691–2718. 35 indexed citations

Johnson, George E., Krista L. Dobo, B. Bhaskar Gollapudi, et al.. (2021). Permitted daily exposure limits for noteworthy N‐nitrosamines. Environmental and Molecular Mutagenesis. 62(5). 293–305. 52 indexed citations

Pacchierotti, Francesca, Kenichi Masumura, David A. Eastmond, et al.. (2019). Chemically induced aneuploidy in germ cells. Part II of the report of the 2017 IWGT workgroup on assessing the risk of aneugens for carcinogenesis and hereditary diseases. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 848. 403023–403023. 12 indexed citations

Kirkland, David, Errol Zeiger, Federica Madia, et al.. (2014). Can in vitro mammalian cell genotoxicity test results be used to complement positive results in the Ames test and help predict carcinogenic or in vivo genotoxic activity? I. Reports of individual databases presented at an EURL ECVAM Workshop. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 775-776. 55–68. 50 indexed citations

Hart, Jo, et al.. (2011). Intrapartales Management von Patientinnen mit vorzeitigem Blasensprung: maternales und fetales Outcome. Geburtshilfe und Frauenheilkunde. 71(8). 1 indexed citations

10.

Avlasevich, Svetlana L., Steven M. Bryce, M. De Boeck, et al.. (2010). Flow cytometric analysis of micronuclei in mammalian cell cultures: past, present and future. Mutagenesis. 26(1). 147–152. 46 indexed citations

11.

Lynch, Anthony. (2003). Investigations into the concept of a threshold for topoisomerase inhibitor-induced clastogenicity. Mutagenesis. 18(4). 345–353. 79 indexed citations

12.

Davies, Donald S., Nigel J. Gooderham, Stephen Murray, et al.. (1996). Chemical Methods for Assessing Systemic Exposure to Dietary Heterocyclic Amines in Man. Archives of toxicology. Supplement. 18. 251–258. 2 indexed citations

13.

Davies, DS, Nigel J. Gooderham, Sandra Murray, et al.. (1995). Systemic exposure to dietary heterocyclic amines in man.. PubMed. 23. 190–6. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact